ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
246.52
-3.52 (-1.41%)
At close: Dec 9, 2025, 4:00 PM EST
257.94
+11.42 (4.63%)
Pre-market: Dec 10, 2025, 8:24 AM EST

ResMed Revenue

ResMed had revenue of $1.34B in the quarter ending September 30, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.26B, up 9.36% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.

Revenue (ttm)
$5.26B
Revenue Growth
+9.36%
P/S Ratio
6.87
Revenue / Employee
$526,794
Employees
9,980
Market Cap
35.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 20192.61B266.38M11.38%
Jun 30, 20182.34B273.46M13.23%
Jun 30, 20172.07B228.02M12.40%
Jun 30, 20161.84B159.80M9.52%
Jun 30, 20151.68B123.94M7.97%
Jun 30, 20141.55B40.52M2.68%
Jun 30, 20131.51B145.94M10.66%
Jun 30, 20121.37B125.37M10.08%
Jun 30, 20111.24B150.79M13.80%
Jun 30, 20101.09B171.62M18.64%
Jun 30, 2009920.74M85.34M10.22%
Jun 30, 2008835.40M119.07M16.62%
Jun 30, 2007716.33M109.34M18.01%
Jun 30, 2006607.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings